Biomarkers—measurable physical signs of a condition—could be a useful way of testing for Alzheimer's disease, according to a new review study.
Apr 27, 2020
0
281
(HealthDay)—In older women, objectively measured visual impairment is associated with a twofold to more than fivefold increased risk for dementia, according to a study published online April 16 in JAMA Ophthalmology.
Apr 23, 2020
0
2
Taking a low-dose aspirin once a day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or probable Alzheimer's disease, nor does it slow the rate of cognitive decline, according ...
Mar 25, 2020
0
150
A standardised test that can now be used in the seven main languages in India will support the diagnosis of dementia and mild cognitive impairment.
Mar 20, 2020
0
0
A blood test that may eventually be done in a doctor's office can swiftly reveal if a patient with memory issues has Alzheimer's disease or mild cognitive impairment and can also distinguish both conditions from frontotemporal ...
Mar 2, 2020
0
192
Currently, best-characterized indicators for Alzheimer's disease (AD) diagnosis are the decreased levels of amyloid β-protein 42 and increased levels of phosphorylated tau in cerebrospinal fluid (CSF). Positron emission ...
Nov 4, 2019
0
7
A new study has found that performing well on two brief tests measuring cognitive ability and ability to identify odors indicates very low risk for Alzheimer's. We know that these tests can help predict the risk of developing ...
Oct 29, 2019
1
7
Even before a dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online ...
Sep 11, 2019
0
7
Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship. However, most of these studies have failed to simultaneously ...
Aug 14, 2019
0
0
The use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, new research presented today at the 5th European Academy of Neurology (EAN) Congress has shown.
Jul 1, 2019
0
1
